Delivered as a once-daily 30 mg/mL IV bolus injection over 15 seconds, Xifyrm can be used alone or alongside non-NSAID ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

US drugmaker Vertex Pharmaceuticals (Nasdaq: VRTX) has announced data across multiple studies demonstrating positive clinical ...

The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce ...

Vertex is laying off 125 employees in Rhode Island and consolidating offices, following the discontinuation of a Type 1 ...

Chronic low back pain (CLBP) is a widespread and long-lasting condition defined by lower back pain that lasts for at least 12 weeks. The l ...

Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) Goldman Sachs 46th Annual Global Healthcare Conference Call June 10, 2025 2:40 PM ET David M. Altshuler - Executive VP & Chief Scientific Officer ...

Crispr Therapeutics AG leverages CASGEVY's rollout, a robust pipeline in cardiovascular, oncology, & partnerships to large ...

UT Health San Antonio Multispecialty and Research Hospital says it’s the first in Texas to add a new non-opioid medication to ...

Amid a challenging gene editing climate, partnerships between researchers, regulators, and industry remain crucial for ...

Detailed price information for Compass Inc Cl A (COMP-N) from The Globe and Mail including charting and trades.

Major global pharmaceutical companies traded lower in the premarket on Tuesday after President Donald Trump reiterated his ...